Michael A Henning sold $82k of CLAR
director at Clarus Corp. 18,309 shares at an average of $4.50, traded Nov 15, 2024, filed Nov 18, 2024.
Score components
- +15RoleDirector
- +9Trade size$82k at market
- +5Share of holdings soldSold 18% of holdings
- 0ClusterNo other insider selling within 14 days
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m +7.1%, 3m +15.2%, 6m -24.1%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001104659-24-120141, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Nov 15, 2024 | SOpen-market sale Common Stock, par value $0.0001 per share ("Common Stock") | -18,309 | $4.50 | $82k | 85,000 | Nov 18, 2024 |
Related signals
Other insiders at Clarus Corp and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 29Weak | CLARbuy Clarus Corp | Warren B Kanders Executive Chairman | $40k 11,399 shares | +0% | |
| 24Weak | CLARbuy Clarus Corp | Nicolas Sokolow director | $90k 22,000 shares | +4% | |
| 38Weak | CLARsell Clarus Corp | Michael A Henning director | $230k 51,691 shares | -33% | |
| 38Weak | CLARbuy Clarus Corp | Nicolas Sokolow director | $443k 100,000 shares | +22% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.